michigan semaglutide bowel obstruction lawsuit GLP-1 receptor agonists may cause emotional flattening michigan semaglutide gastric intestinal obstruction

The Medicare Prescription Drug, Improvement, and Modernization Act (MMA) of 2003 determined that Part D prescriptions could not cover medications for cosmetic or weight loss reasons

2020 Sep;53:102514

However, in a 2023 study, participants were given 0.5mg of semaglutide per week, and both Ozempic and Wegovy are available in that dose

With approximately 20-30% of adults experiencing some degree of needle phobia according to published research, the availability of oral alternatives opens physician-supervised metabolic health treatment to millions of individuals who have avoided these therapies despite medical appropriateness and clinical need